{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-008143","form_type":"8-K","ticker":"NATR","cik":"0000275053","company_name":"NATURES SUNSHINE PRODUCTS INC","filed_at":"2023-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.557741+00:00","generated_at":"2026-06-18T01:10:40.014063+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nature's Sunshine Q4 net sales $102.7M (-6.4% cc); GAAP EPS $0.10; FY adjusted EBITDA $32M","bullets":["Q4 net sales $102.7M, down 6.4% in constant currency vs year-ago; GAAP net income $2.0M ($0.10/sh).","Q4 adjusted EBITDA $8.0M vs $11.6M prior year; gross margin 72.2% vs 74.0%.","Full year 2022 net sales $421.9M, up 0.2% constant currency; GAAP net loss $0.4M ($0.02/sh).","Full year adjusted EBITDA $32.0M vs $49.4M in 2021; foreign exchange and cost headwinds cited.","Asia segment grew 5.3% (16.1% constant currency); Europe and North America sales declined."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-008143","json":"https://secwatch.observer/filing/0001628280-23-008143.json","markdown":"https://secwatch.observer/filing/0001628280-23-008143.md","text":"https://secwatch.observer/filing/0001628280-23-008143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/275053/000162828023008143/0001628280-23-008143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/275053/000162828023008143/natr-20230315.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T01:10:40.014063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b3cbc9c6d7c301e7de89449933d846ab1f438e8","claim":"NATURES SUNSHINE PRODUCTS INC reported fourth quarter and full year ended December 31, 2022 results: revenue $102.7 million, net income $2.1 million, EPS $0.10 per diluted share.","evidence_excerpt":"reported financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights vs. Same Year-Ago Quarter • Net sales were $102.7 million compared to $117.9 million (down 6.4% in constant currency). • GAAP net income was $2.1 million, or $0.10 per diluted share, compared to $13.8 million, or $0.67 per diluted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/275053/000162828023008143/0001628280-23-008143-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year ended December 31, 2022"},{"label":"Revenue","value":"$102.7 million"},{"label":"Net income","value":"$2.1 million"},{"label":"EPS","value":"$0.10 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}